Table 2.

Echocardiographic variables in the study population

Echocardiography dataPatients
LV function and remodeling  
LVEF in Simpson biplane (%) 57.7 ± 5.8 
LVEF < 50%, n (%) 6 (6) 
GLS (%) –17.9 ± 2.7 
GLS > –18% 51 (51) 
Cardiac output (L/min) 6.2 ± 1.7 
End-diastolic ventricular diameter (mm) 55.7 ± 6.7 
Indexed LV volume (mL/m280.6 ± 24.8 
Indexed LV mass (g/m2110.2 ± 37.7 
Diastolic function  
E (cm/s) 87 ± 21 
EDT (ms) 192 ± 46 
A (cm/s) 64 ± 20 
E/A 1.5 ± 0.6 
E' lateral (cm/s) 12.7 ± 3.7 
E/E' lateral 7.8 ± 2.9 
Indexed LA volume (mL/m257.2 ± 19.8 
RV function and right pressures  
TAPSE (mm) 25.6 ± 5.4 
S-wave (cm/s) 14.6 ± 2.5 
TRV (m/s), n = 97 2.6 ± 0.3 
TRV ≥ 3 m/s, n (%) 18 (19) 
Pulmonary acceleration time (ms) 133.4 ± 31.4 
Indexed tricuspid ring (mm/m219.4 ± 3.2 
RV end-diastolic area (cm220.9 ± 5.0 
Telesystolic area of the right atrium (cm220.1 ± 5.4 
Systolic pulmonary arterial pressure (mmHg) 32.4 ± 8.6 
Right atrium pressure (mmHg) 4.2 ± 2.7 
Valve disease  
Severe valve disease (grade 4), n (%) 0 (0) 
Mild to moderate valve disease (grade 2 and 3), n (%) 10 (10) 
Echocardiography dataPatients
LV function and remodeling  
LVEF in Simpson biplane (%) 57.7 ± 5.8 
LVEF < 50%, n (%) 6 (6) 
GLS (%) –17.9 ± 2.7 
GLS > –18% 51 (51) 
Cardiac output (L/min) 6.2 ± 1.7 
End-diastolic ventricular diameter (mm) 55.7 ± 6.7 
Indexed LV volume (mL/m280.6 ± 24.8 
Indexed LV mass (g/m2110.2 ± 37.7 
Diastolic function  
E (cm/s) 87 ± 21 
EDT (ms) 192 ± 46 
A (cm/s) 64 ± 20 
E/A 1.5 ± 0.6 
E' lateral (cm/s) 12.7 ± 3.7 
E/E' lateral 7.8 ± 2.9 
Indexed LA volume (mL/m257.2 ± 19.8 
RV function and right pressures  
TAPSE (mm) 25.6 ± 5.4 
S-wave (cm/s) 14.6 ± 2.5 
TRV (m/s), n = 97 2.6 ± 0.3 
TRV ≥ 3 m/s, n (%) 18 (19) 
Pulmonary acceleration time (ms) 133.4 ± 31.4 
Indexed tricuspid ring (mm/m219.4 ± 3.2 
RV end-diastolic area (cm220.9 ± 5.0 
Telesystolic area of the right atrium (cm220.1 ± 5.4 
Systolic pulmonary arterial pressure (mmHg) 32.4 ± 8.6 
Right atrium pressure (mmHg) 4.2 ± 2.7 
Valve disease  
Severe valve disease (grade 4), n (%) 0 (0) 
Mild to moderate valve disease (grade 2 and 3), n (%) 10 (10) 

Ordinal data are reported as mean ± standard deviation and nominal data as absolute value and percentage.

A, mitral end-diastolic velocity; ASE, American Society of Echocardiography; E, mitral protodiastolic velocity; E', mitral protodiastolic annular velocity; EDT, E wave deceleration time; LA left atrium; LV, left ventricle; S, tricuspid annular mesosystolic velocity; TAPSE, tricuspid annular plane systolic excursion.

or Create an Account

Close Modal
Close Modal